01 9Boehringer Ingelheim (Canada) Ltd.
01 32277949
02 32476054
03 32537054
01 9Dabigatran Etexilate Mesilate
01 3Capsule
02 6Hard Capsule
01 32018-02-16
02 32023-03-03
03 32024-08-24
Patent Expiration Date : 2018-02-16
Date Granted : 2006-10-03
Brand Name : PRADAXA
Patent Number : 2277949
Filing Date : 1998-02-16
Strength per Unit : 75 mg
Dosage Form : Hard Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-02-16
Date Granted : 2006-10-03
Patent Expiration Date : 2018-02-16
Date Granted : 2006-10-03
Brand Name : PRADAXA
Patent Number : 2277949
Filing Date : 1998-02-16
Strength per Unit : 110 mg
Dosage Form : Hard Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-02-16
Date Granted : 2006-10-03
Patent Expiration Date : 2023-03-03
Date Granted : 2011-11-08
Brand Name : PRADAXA
Patent Number : 2476054
Filing Date : 2003-03-03
Strength per Unit : 75 mg
Dosage Form : Hard Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-03-03
Date Granted : 2011-11-08
Patent Expiration Date : 2024-08-24
Date Granted : 2011-12-06
Brand Name : PRADAXA
Patent Number : 2537054
Filing Date : 2004-08-24
Strength per Unit : 75 mg
Dosage Form : Hard Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-08-24
Date Granted : 2011-12-06
Patent Expiration Date : 2023-03-03
Date Granted : 2011-11-08
Brand Name : PRADAXA
Patent Number : 2476054
Filing Date : 2003-03-03
Strength per Unit : 110 mg
Dosage Form : Hard Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-03-03
Date Granted : 2011-11-08
Patent Expiration Date : 2024-08-24
Date Granted : 2011-12-06
Brand Name : PRADAXA
Patent Number : 2537054
Filing Date : 2004-08-24
Strength per Unit : 110 mg
Dosage Form : Hard Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-08-24
Date Granted : 2011-12-06
Patent Expiration Date : 2018-02-16
Date Granted : 2006-10-03
Brand Name : PRADAXA
Patent Number : 2277949
Filing Date : 1998-02-16
Strength per Unit : 150 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-02-16
Date Granted : 2006-10-03
Patent Expiration Date : 2023-03-03
Date Granted : 2011-11-08
Brand Name : PRADAXA
Patent Number : 2476054
Filing Date : 2003-03-03
Strength per Unit : 150 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-03-03
Date Granted : 2011-11-08
Patent Expiration Date : 2024-08-24
Date Granted : 2011-12-06
Brand Name : PRADAXA
Patent Number : 2537054
Filing Date : 2004-08-24
Strength per Unit : 150 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-08-24
Date Granted : 2011-12-06
